Stevenage, United Kingdom

Chuen Chan


Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Ickenham, GB (1991 - 1992)
  • Hertfordshire, GB (2004)
  • Stevenage, DE (2007)
  • Stevenage, GB (2002 - 2009)

Company Filing History:


Years Active: 1991-2009

Loading Chart...
15 patents (USPTO):Explore Patents

Introduction

Chuen Chan is a distinguished inventor based in Stevenage, GB, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 15 patents, Chan's work focuses primarily on innovative compounds that enhance medical treatments. His latest inventions highlight the potential for improving therapeutic outcomes in patients requiring Factor Xa inhibitors.

Latest Patents

Among his recent patents, Chan has developed pyrrolidine derivatives that serve as effective Factor Xa inhibitors. The invention details specific compounds, their preparation processes, and pharmaceutical compositions containing these compounds. The research emphasizes their applicability in medicine, particularly in the amelioration of clinical conditions benefiting from Factor Xa inhibition. This innovative approach has the potential to significantly impact treatment protocols in various medical scenarios.

Career Highlights

Throughout his career, Chuen Chan has been associated with prominent pharmaceutical companies, such as Glaxo Group Limited and SmithKline Beecham Corporation. His work at these organizations has allowed him to refine his expertise in pharmaceutical research and development, greatly contributing to his success as an inventor. His extensive experience in the industry has positioned him as a key player in the advancement of therapeutic inventions.

Collaborations

Chan has collaborated with several notable professionals in the field. Among his coworkers are Nigel Stephen Watson and Henry Anderson Kelly, who have contributed to his journey as an inventor. These collaborations have not only enriched his research but have also fostered innovative approaches to tackling complex pharmaceutical challenges.

Conclusion

In conclusion, Chuen Chan is a notable figure in the landscape of pharmaceutical innovation. With a focus on developing effective Factor Xa inhibitors through his patented inventions, he continues to advance medical science and improve patient care. His contributions underscore the importance of inventive research and collaboration in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…